Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer
The Oncologist · 07.10.2026 · 31 (11)
DOI: 10.1093/oncolo/oyag412 ↗Kurz gefasst
Editorial in der Zeitschrift The Oncologist, online erschienen am 26.10.2026. Verfasst von Varun Nandakumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Cancer Consortium, Boston, MA 02215, United States.
ORCID-Profile: Varun Nandakumar, Georges Gebrael, Neeraj Agarwal
Zitieren
APA
Nandakumar, V., Gebrael, G., & Agarwal, N. (2026). Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer. The Oncologist, 31(11). https://doi.org/10.1093/oncolo/oyag412
Vancouver
Nandakumar V, Gebrael G, Agarwal N. Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer. The Oncologist. 2026;31(11). doi:10.1093/oncolo/oyag412
BibTeX
@article{Nandakumar2026,
author = {Nandakumar, Varun and Gebrael, Georges and Agarwal, Neeraj},
title = {Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {11},
doi = {10.1093/oncolo/oyag412}
}
EUVIMED